How does intensive blood pressure control reduce the risk of cardiovascular disease events? A biomarker-based mediation analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)

被引：0
|
作者：
Segar, Matthew
Khan, Safi
Nasir, Khurram
Shafi, Tariq
Januzzi, James
Arora, Pankaj
Butler, Javed
Patel, Kershaw
机构：
来源：
CIRCULATION | 2024年 / 150卷
关键词：
D O I：
10.1161/circ.150.suppl_1.4144426
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4144426
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Intensive blood pressure control and outcomes in hypertensive patients with dysglycemia - Study of Glasgow Blood Pressure (GBPC) Clinic and Systolic Blood Pressure Intervention Trial (SPRINT) data
    Llano, Andrea
    McCallum, Linsay
    Dominiczak, Anna
    Petrie, John
    Padmanabhan, Sandosh
    JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (10) : 667 - 668
  • [32] Pulse pressure and cardiovascular outcomes in high-risk individuals enrolled in the Systolic Blood Pressure Intervention Trial (SPRINT)
    Pareek, M.
    Biering-Sorensen, T.
    Vaduganathan, M.
    Byrne, C.
    Olsen, M. H.
    Bhatt, D. L.
    EUROPEAN HEART JOURNAL, 2018, 39 : 56 - 56
  • [33] Cardiovascular Outcomes in Adults With Systolic Blood Pressure Between 130 and 139 mmHg at Screening in the Systolic Blood Pressure Intervention Trial (SPRINT)
    Contreras, Gabriel
    Lu, Lingyi
    Tamariz, Leonardo
    Rocco, Michael
    Papademetriou, Vasilios
    Kostis, John B.
    Pisoni, Roberto
    Glasser, Stephen P.
    Sweeney, Mary Ellen
    Basile, Jan
    Gren, Lisa H.
    Zamanian, Sara
    Cushman, William C.
    CIRCULATION, 2018, 138
  • [34] Visit-to-Visit Office Blood Pressure Variability and Cardiovascular Outcomes in SPRINT (Systolic Blood Pressure Intervention Trial)
    Chang, Tara I.
    Reboussin, David M.
    Chertow, Glenn M.
    Cheung, Alfred K.
    Cushman, William C.
    Kostis, William J.
    Parati, Gianfranco
    Raj, Dominic
    Riessen, Erik
    Shapiro, Brian
    Stergiou, George S.
    Townsend, Raymond R.
    Tsioufis, Konstantinos
    Whelton, Paul K.
    Whittle, Jeffrey
    Wright, Jackson T.
    Papademetriou, Vasilios
    HYPERTENSION, 2017, 70 (04) : 751 - +
  • [35] Outcomes in adults with systolic blood pressure between 130 and 139 mmHg in Action to Control Cardiovascular Risk in Diabetes Blood Pressure trial and Systolic Blood Pressure Intervention Trial
    Contreras, Gabriel
    Lu, Lingyi
    Tamariz, Leonardo
    Rocco, Michael V.
    Papademetriou, Vasilios
    Kostis, John B.
    Pisoni, Roberto
    Glasser, Stephen P.
    Sweeney, Mary E.
    Basile, Jan
    Gren, Lisa H.
    Zamanian, Sara
    Cushman, William C.
    JOURNAL OF HYPERTENSION, 2020, 38 (08) : 1567 - 1577
  • [36] Effect of intensive blood pressure lowering on cardiovascular outcomes based on cardiovascular risk: A secondary analysis of the SPRINT trial
    Attar, Armin
    Sayadi, Mehrab
    Jannati, Mansoor
    EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY, 2019, 26 (03) : 238 - 245
  • [37] EFFECT OF INTENSIVE BLOOD PRESSURE TREATMENT ACCORDING TO BASELINE FRAMINGHAM RISK SCORE: RESULTS FROM SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL (SPRINT)
    Zhuang, Xiaodong
    Sun, Xiuting
    Zhou, Huimin
    Guo, Yue
    Liao, Xinxue
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1917 - 1917
  • [38] The use of four or more drugs for intensive control of blood pressure is associated with detrimental renal effects in Systolic Blood Pressure Intervention Trial (SPRINT)
    McCallum, Linsay
    Dasgupta, Indranil
    Jardine, Alan
    Padmanabhan, Sandosh
    JOURNAL OF HUMAN HYPERTENSION, 2017, 31 (10) : 657 - 658
  • [39] A critical review of the systolic blood pressure intervention trial (SPRINT)
    Kjeldsen, Sverre E.
    Mancia, Giuseppe
    EUROPEAN HEART JOURNAL, 2017, 38 (44) : 3260 - 3265
  • [40] Assessment of Long-term Benefit of Intensive Blood Pressure Control on Residual Life Span Secondary Analysis of the Systolic Blood Pressure Intervention Trial (SPRINT)
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Juraschek, Stephen P.
    Solomon, Scott D.
    JAMA CARDIOLOGY, 2020, 5 (05) : 576 - 581
12345